(Total Views: 511)
Posted On: 03/31/2025 5:51:42 PM
Post# of 151548
sean: I fear you are misinterpreting what you characterize as a "45 minute speech/lecture" by Dr Pestell at ESMO. CYDY's poster presentation will be 1 of almost 500 that will be on display in the "Hall" during the lunch hour, 12:00 - 12-45, that day. I know the program lists Dr Pestell as "speaker" with respect to our poster presentation, but a "speaker" is also listed for all of the almost 500 other poster presentations.
I am interpreting the above logistics as describing several hundred posters set up that day in the main hall as a lunch hour walk around for the attendees, with a "speaker" standing there to perhaps say a few words of introduction answer questions, and glad hand those showing interest.. I hope I am wrong, but perhaps Kat, Respert, or one of our doctors who has attended one of these large conferences can explain how this is likely to play out.
Dr Pestell, however, will be a primary speaker at the 11th World Cancer Conference in Berlin on July 7 or 8 on the topic of Leronlimab blocking breast cancer metastasis. That speech,I think, may well be a big deal.
To me, both of these long trips to Europe by Dr Pestell seem much more suited to deliver the news of what LL can do to treating oncologists and primary physicians, who are the primary attendees at these conferences, rather than as an exercise to find an oncology partner. If CYDY has to send Dr Pestell to Germany twice to bring LL to the attention of GSK, Merck, and Gilead, we are in serious trouble. But announcing the updated mTNBC survival data at Esmo, either just before or just after a partnership announcement, would make total sense as a means of calming the reaction of our new partner's shareholders and increasing the sp by attracting new shareholders.
Then Berlin, 9 weeks later, for Pestell's speech to the entire audience, would make much more sense if LL had just been granted, or was about to be granted, accelerated approval to treat mTNBC, perhaps in Europe. After all, what is the point of approval if the necessary prescribing physicians have never heard of LL? And if approval for mTNBC is still years away, would Dr Jay expect that Dr Pestell's speech in Berlin in July, 2025 would still be remembered by the Berlin attendees then? Just asking.
I am interpreting the above logistics as describing several hundred posters set up that day in the main hall as a lunch hour walk around for the attendees, with a "speaker" standing there to perhaps say a few words of introduction answer questions, and glad hand those showing interest.. I hope I am wrong, but perhaps Kat, Respert, or one of our doctors who has attended one of these large conferences can explain how this is likely to play out.
Dr Pestell, however, will be a primary speaker at the 11th World Cancer Conference in Berlin on July 7 or 8 on the topic of Leronlimab blocking breast cancer metastasis. That speech,I think, may well be a big deal.
To me, both of these long trips to Europe by Dr Pestell seem much more suited to deliver the news of what LL can do to treating oncologists and primary physicians, who are the primary attendees at these conferences, rather than as an exercise to find an oncology partner. If CYDY has to send Dr Pestell to Germany twice to bring LL to the attention of GSK, Merck, and Gilead, we are in serious trouble. But announcing the updated mTNBC survival data at Esmo, either just before or just after a partnership announcement, would make total sense as a means of calming the reaction of our new partner's shareholders and increasing the sp by attracting new shareholders.
Then Berlin, 9 weeks later, for Pestell's speech to the entire audience, would make much more sense if LL had just been granted, or was about to be granted, accelerated approval to treat mTNBC, perhaps in Europe. After all, what is the point of approval if the necessary prescribing physicians have never heard of LL? And if approval for mTNBC is still years away, would Dr Jay expect that Dr Pestell's speech in Berlin in July, 2025 would still be remembered by the Berlin attendees then? Just asking.
(20)
(0)Scroll down for more posts ▼
